Fluoride-Related Bone Disease Associated With Habitual Tea Consumption

Johnson, Julie E. Hallanger; Kearns, Ann E.; Doran, Patrick M.; Teck Kim Khoo; Wermers, Robert A.
June 2007
Mayo Clinic Proceedings;Jun2007, Vol. 82 Issue 6, p719
Academic Journal
Acquired osteosclerosis is a rare disorder of bone formation but an important consideration in adults with sclerotic bones or elevated bone density results, in such patients, malignancy, hepatitis C, and fluorosis should all be considered when making a diagnosis. We describe 4 patients evaluated at our Metabolic Bone Disease Clinic from May 1, 1997, to July 1, 2006, whose bone disorders resulted from chronic fluoride exposure due to excessive tea intake. Three of these patients had toxic serum fluoride levels (>15 μmol/L). Although the clinical presentation of the patients varied, all 4 had an unexpectedly elevated spine bone mineral density that was proportionately higher than the bone mineral density at the hip. Other clinical features included gastrointestinal symptoms such as nausea, vomiting, and weight loss; lower extremity pain sometimes associated with stress fractures of the lower extremities; renal insufficiency; and elevated alkaline phosphatase levels. Readily available, tea often contains high levels of fluoride. Obsessive-compulsive drinking behaviors and renal insufficiency may predispose to excessive fluoride consumption and accumulation. The current cases show that fluoride-related bone disease is an important clinical consideration in patients with dense bones or gastrointestinal symptoms and a history of excessive tea consumption. Furthermore, fluoride excess should be considered in all patients with a history of excessive tea consumption, especially due to its insidious nature and nonspecific clinical presentation.


Related Articles

  • Herbal medicines.  // Reactions Weekly;10/14/2006, Issue 1123, p13 

    The article presents a case report of a 46-year-old woman who started using extracts of Chinese green tea. Seven months later, she developed jaundice. Her peak serum total bilirubin level was 211, her alkaline phosphatase level was 194 U/L, and her AST and ALT levels were 1188 U/L and 1100 U/L,...

  • Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. Fiore, C.; Riccobene, S.; Mangiafico, R.; Santoro, F.; Pennisi, P. // Osteoporosis International;Dec2005, Vol. 16 Issue 12, p2180 

    We report a new case of hepatitis C-associated osteosclerosis (HCAO). The clinical presentation of the patient was an acquired deep severe bone pain with increased serum bone alkaline phosphatase activity (up to 12 times the upper limit of normal), and generalized bone sclerosis, temporally...

  • Three-year extension study of lanthanum carbonate therapy in Japanese hemodialysis patients. Shigematsu, Takashi // Clinical & Experimental Nephrology;Dec2010, Vol. 14 Issue 6, p589 

    Background: Lanthanum carbonate is a non-aluminum, non-calcium phosphate binder. Its efficacy and its safety profile up to 1 year have been reported in Japanese hemodialysis patients. Methods: The present study was an extension of the earlier study. One hundred and forty-five patients were...

  • Occurrence of Immunoglobulin G-Alkaline Phosphatase Complexes in Human Serum. De Broe, Marc E.; Mets, Tony E.; Leroux-Roels, Geert G.; Wieme, Roger J. // Annals of Internal Medicine;Jan79, Vol. 90 Issue 1, p30 

    Presents a study which provided evidence for the presence of a complex between alkaline phosphatase of liver or bone origin and immunoglobulin G circulating in the serum of three patients. Medical history of the patients; Method used to identify serum alkaline phosphatase isozymes; Outcome of...

  • Assessment of markers of bone formation under controlled environmental factors and their correlation with serum minerals in adult sheep as a model for orthopaedic research. Dias, I. R.; Viegas, C. A.; de Azevedo, J. T.; Costa, E. M.; Lourenço, P.; Rodrigues, A.; Cabrita, A. S. // Laboratory Animals;Oct2008, Vol. 42 Issue 4, p465 

    Eighteen healthy skeletally mature (3 years old) ewes, with an average weight of 45 kg, of the Portuguese Churra da Terra Quente breed were used to evaluate the normal values of total and bone-specific isoform of alkaline phosphatase serum activities (ALP and BALP, respectively) and serum...

  • The Role of Circulating Bone Cell Precursors in Fracture Healing. D'Amelio, Patrizia; Cristofaro, Maria Angela; Grimaldi, Anastasia; Ravazzoli, Marco; Pluviano, Fernanda; Grosso, Elena; Pescarmona, Gian Pero; Isaia, Giovanni Carlo // Calcified Tissue International;Jun2010, Vol. 86 Issue 6, p463 

    Fracture healing is a complex process that involves several cell types; as a previous report suggested an increase in osteoblast (OB) precursors in peripheral blood during this process, this paper examines the role of circulating bone cell precursors in this process in the light of a prior...

  • Biological Variability in Serum and Urinary Indices of Bone Formation and Resorption in Dogs. Ladlow, J. F.; Hoffmann, W. E.; Breur, G. J.; Richardson, D. C.; Allen, M. J. // Calcified Tissue International;Mar2002, Vol. 70 Issue 3, p186 

    Serum and urinary assays of bone markers provide a noninvasive alternative to bone biopsy in the study of bone metabolism in humans. Many of the commercial assays that were originally developed for use in humans have been shown to cross-react in dogs, and it should therefore be possible to use...

  • Hepatoprotective Activity of Ethanolic Extract of Ficus nervosa on Paracetamol Induced Hepatotoxicity in Wistar Rats. Shireesha, T.; Jayaveera, K. N.; Ravindra Reddy, K. // Journal of Pharmacy Research;2012, Vol. 5 Issue 7, p3892 

    Ethanol extract of Ficus nervosa (moraceae) was evaluated for hepatoprotective activity in rats. The plant extract (500 mg/kg, p.o.) showed a remarkable hepatoprotective activity against paracetmol induced hepatotoxicity as judged from the serum markers for liver damage. Paracetmol induced a...

  • Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort. op den Winkel, Mark; Nagel, Dorothea; Sappl, Julia; op den Winkel, Philip; Lamerz, Rolf; Zech, Christoph J.; Straub, Gundula; Nickel, Thomas; Rentsch, Markus; Stieber, Petra; Göke, Burkhard; Kolligs, Frank T. // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Background: HCC is diagnosed in approximately half a million people per year, worldwide. Staging is a more complex issue than in most other cancer entities and, mainly due to unique geographic characteristics of the disease, no universally accepted staging system exists to date. Focusing on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics